123 related articles for article (PubMed ID: 38235779)
1. The Rising Incidence and Poor Outcomes of Enteropathy-Associated T-Cell Lymphoma.
Hujoel IA; Hujoel MLA
Am J Gastroenterol; 2024 Feb; ():. PubMed ID: 38235779
[TBL] [Abstract][Full Text] [Related]
2. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.
Sharaiha RZ; Lebwohl B; Reimers L; Bhagat G; Green PH; Neugut AI
Cancer; 2012 Aug; 118(15):3786-92. PubMed ID: 22169928
[TBL] [Abstract][Full Text] [Related]
3. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
5. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
6. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
7. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
8. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Sieniawski M; Angamuthu N; Boyd K; Chasty R; Davies J; Forsyth P; Jack F; Lyons S; Mounter P; Revell P; Proctor SJ; Lennard AL
Blood; 2010 May; 115(18):3664-70. PubMed ID: 20197551
[TBL] [Abstract][Full Text] [Related]
10. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Delabie J; Holte H; Vose JM; Ullrich F; Jaffe ES; Savage KJ; Connors JM; Rimsza L; Harris NL; Müller-Hermelink K; Rüdiger T; Coiffier B; Gascoyne RD; Berger F; Tobinai K; Au WY; Liang R; Montserrat E; Hochberg EP; Pileri S; Federico M; Nathwani B; Armitage JO; Weisenburger DD
Blood; 2011 Jul; 118(1):148-55. PubMed ID: 21566094
[TBL] [Abstract][Full Text] [Related]
11. Enteropathy-associated T-cell lymphoma (type II): a Brazilian case report.
Felipe-Silva A; de Campos FPF; de Medeiros RSS; Lourenção RM; Zerbini MCN
Autops Case Rep; 2012; 2(2):31-36. PubMed ID: 31528569
[TBL] [Abstract][Full Text] [Related]
12. Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort.
Nijeboer P; de Baaij LR; Visser O; Witte BI; Cillessen SA; Mulder CJ; Bouma G
Am J Hematol; 2015 Jun; 90(6):493-8. PubMed ID: 25716069
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Shah UA; Shah N; Qiao B; Acuna-Villaorduna A; Pradhan K; Adrianzen Herrera D; Sica RA; Shastri A; Mantzaris I; Derman O; Kornblum N; Braunschweig I; Ye BH; Verma A; Janakiram M
Cancer; 2020 Feb; 126(3):567-574. PubMed ID: 31769871
[TBL] [Abstract][Full Text] [Related]
14. Hematemesis as an Initial Presentation of Enteropathy-Associated T-Cell Lymphoma.
Bassi M; Mohapatra S; Sharma P; Korman A; Pitchumoni CS; Broder A
Cureus; 2021 Aug; 13(8):e16992. PubMed ID: 34377617
[TBL] [Abstract][Full Text] [Related]
15. Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands.
Verbeek WH; Van De Water JM; Al-Toma A; Oudejans JJ; Mulder CJ; Coupé VM
Scand J Gastroenterol; 2008; 43(11):1322-8. PubMed ID: 18618372
[TBL] [Abstract][Full Text] [Related]
16. Enteropathy associated T-cell lymphoma and its precursor lesions.
van de Water JM; Cillessen SA; Visser OJ; Verbeek WH; Meijer CJ; Mulder CJ
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):43-56. PubMed ID: 20206108
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series.
Hong YS; Woo YS; Park G; Lee K; Kang SH; Lee HW; Kim ER; Hong SN; Chang DK; Kim YH; Rhee PL; Kim JJ
Gut Liver; 2016 Jan; 10(1):147-51. PubMed ID: 26260757
[TBL] [Abstract][Full Text] [Related]
18. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.
Wierdsma NJ; Nijeboer P; de van der Schueren MA; Berkenpas M; van Bodegraven AA; Mulder CJ
Clin Nutr; 2016 Jun; 35(3):685-91. PubMed ID: 25979847
[TBL] [Abstract][Full Text] [Related]
19. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
20. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.
Sieniawski MK; Lennard AL
Curr Hematol Malig Rep; 2011 Dec; 6(4):231-40. PubMed ID: 21912848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
